AliveX Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
50
- Latest Deal Type
-
Out of Business
AliveX General Information
Description
Developer of an artificial intelligence-driven immunology platform designed to focus on biomarker discovery. The company's platform combines multi-omics data and computational biology to decode the human immune system, enabling immunologists, molecular biologists, and clinical experts to solve the most pressing clinical challenges and transform life sciences research, and develop diagnostics.
Contact Information
Website
www.alivexbiotech.comCorporate Office
- Level 2, Merewether Building H04
- Sydney, New South Wales 2006
- Australia
Corporate Office
- Level 2, Merewether Building H04
- Sydney, New South Wales 2006
- Australia
AliveX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Aug-2025 | Completed | Out of Business | |||
| 2. Early Stage VC | 28-Jun-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 28-Dec-2020 | Completed | Generating Revenue |
AliveX Signals
AliveX FAQs
-
When was AliveX founded?
AliveX was founded in 2019.
-
Where is AliveX headquartered?
AliveX is headquartered in Sydney, Australia.
-
What is the size of AliveX?
AliveX has 50 total employees.
-
What industry is AliveX in?
AliveX’s primary industry is Discovery Tools (Healthcare).
-
Is AliveX a private or public company?
AliveX is a Private company.
-
What is AliveX’s current revenue?
The current revenue for AliveX is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process